Wellmarker Bio Co., Ltd., which spin-off from Asan Hospital in Seoul, has its own distinctive features: development of new drugs that consider unmet medical demand based on abundant hospital-based clinical data, and biomarker technology for predicting treatment response to this. Wellmarker
Bio, an innovative new drug development company consisting of Target Discovery Research Center, Drug Discovery Research Center, Pharmaceut...
Wellmarker Bio Co., Ltd., which spin-off from Asan Hospital in Seoul, has its own distinctive features: development of new drugs that consider unmet medical demand based on abundant hospital-based clinical data, and biomarker technology for predicting treatment response to this. Wellmarker
Bio, an innovative new drug development company consisting of Target Discovery Research Center, Drug Discovery Research Center, Pharmaceutical Chemistry Research Center, and CMC Research Center, will contribute to the healthy life of humanity around the world through the development of new drugs based on biomarker predicting treatment response.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.